Novo Nordisk A-S
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $85,683,000 | $71,311,000 | $68,060,000 | $65,349,000 |
Gross Profit | 72,659,000 | 60,003,000 | 57,786,000 | 55,433,000 |
EBITDA | 40,142,000 | 37,355,000 | 35,739,000 | 35,328,000 |
EBIT | 34,944,000 | 35,205,000 | 26,894,000 | 32,414,000 |
Net Income | 28,230,000 | 27,301,000 | 20,050,000 | 25,407,000 |
Net Change In Cash | 85,683,000 | 71,311,000 | 68,060,000 | 65,349,000 |
Free Cash Flow | -4,257,000 | 31,731,000 | 37,265,000 | 5,305,000 |
Cash | 15,655,000 | 57,018,000 | 52,821,000 | 6,324,000 |
Basic Shares | 4,460,500 | 4,460,500 | 4,465,400 | 4,470,500 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $290,403,000 | $232,261,000 | $176,954,000 | $140,800,000 |
Gross Profit | 245,881,000 | 196,496,000 | 148,506,000 | 117,142,000 |
EBITDA | 137,376,000 | 113,331,000 | 76,412,000 | 64,826,000 |
EBIT | 128,831,000 | 103,918,000 | 69,810,000 | 59,515,000 |
Net Income | 100,988,000 | 83,683,000 | 55,525,000 | 47,757,000 |
Net Change In Cash | 290,403,000 | 232,261,000 | 176,954,000 | 140,800,000 |
Free Cash Flow | 69,659,000 | 70,012,000 | 64,134,000 | 47,615,000 |
Cash | 15,655,000 | 14,392,000 | 12,653,000 | 10,720,000 |
Basic Shares | 4,460,500 | 4,494,800 | 4,544,600 | 4,606,200 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $6.34 |
2024-09-30 | $0.90 |
2024-06-30 | $0.66 |
2024-03-31 | $0.83 |
